821. Deputy David Cullinane asked the Minister for Health to outline the breakdown of actual spending within the medicines budget from 2020 to 2024, distinguishing between off-patent medicines, including generic and biosimilar medicines and new or originator medicines; and to provide an estimate of the total savings generated for the State by the off-patent medicines industry during the same period, specifically those resulting from the launch of generic or biosimilar medicines following the expiration of originator patents. [6305/25]

Summary

821. Deputy David Cullinane asked the Minister for Health to outline the breakdown of actual spending within the medicines budget from 2020 to 2024, distinguishing between off-patent medicines, including generic and biosimilar medicines and new or originator medicines; and to provide an estimate of the total savings generated for the State by the off-patent medicines industry during the same period, specifically those resulting from the launch of generic or biosimilar medicines following the expiration of originator patents. [6305/25]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 18 February 2025

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.